课题基金 / 基金详情

Mechanisms of Carcinogenesis in BRCA2 Mutant Cells

Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
BRCA2突变细胞的致癌机制
批准号:
6514387
负责人:
Jeffrey T Holt
金额:
$37.35万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-06-01 至 2006-05-31

项目摘要

项目成果

Jeffrey T Holt的其他基金

相似基金

相关文献

中文摘要
翻译
BRCA2基因是一种癌症易感基因,在乳腺癌、前列腺癌、卵巢癌、食道癌和胰腺癌中成熟。作为对这一批评的回应,我们明显修改了这一建议,研究小鼠BRCA2缺陷细胞(BRCA2-),而不是人BRCA2缺陷Vance细胞,因为小鼠细胞中的遗传缺陷更简单。我们在小鼠BRCA2-细胞中的初步数据表明,在BRCA2缺陷细胞中,RAD51迅速被caspase-3切割,BRCA2或RAD51的过表达或caspase-3的抑制逆转了放射性和DNA修复缺陷。抗caspase-3的RAD51突变体(D-A187Rad51)在BRCA2中逆转辐射敏感性和DNA修复--当这两种蛋白都在接近生理水平表达时,其程度比野生型RAD51更大。我们最近已经纯化了RAD51和caspase-3蛋白,以便进行体外机制研究。我们提供的新数据表明,RAD51在BRCA2-中主要是细胞质的,野生型BRCA2的表达将RAD51重新定位到细胞核,而突变型BRCA2的表达不影响RAD51的定位。这些发现导致了以下假设:1.BRCA2在双链DNA断裂修复中正常发挥作用;2.BRCA2和Rda51在同一生化途径中介导DNA修复;3.BRCA2通过抑制caspase-3和其他蛋白酶的降解来稳定RAD51;4.BRCA2影响RAD51的核定位。为了检验假设,我们提出了这些目标。目的1:确定BRCA2蛋白介导双链断裂修复和肿瘤发生的功能结构域。目的2:了解BRCA2缺陷癌细胞中已知的额外突变是否会导致BRCA2细胞的辐射敏感性和DNA修复缺陷。目的:通过体外实验确定BRCA2-RAD51相互作用的机制及其体内意义。目的:分析BRCA2-RAD51基因定位的机制。目的5:建立和应用活体成像方法,实时研究RAD51在活细胞中的定位和DNA修复。
英文摘要
The BRCA2 gene is a cancer predisposition gene, which is matured in breast cancer, prostate cancer, ovarian cancer, esophageal cancer , and pancreatic cancer. In response to the critique, we have markedly modified this proposal to study mouse BRCA2 defective cells (BRCA2--) instead of human BRCA2 defective Vance cells, since the genetic defect in the mouse cells is simpler. Our preliminary data in mouse BRCA2-- cells shows that Rad51 is rapidly cleaved by caspase-3 in BRCA2 defective cells and that overexpression of BRCA2 or Rad51, or inhibition of caspase-3 reverse radioactivity and the DNA repair defect. A caspase-3 resistant Rad51 mutant (D- A187Rad51) reverses radio sensitivity and the DNA repair in brca2-- to a greater extent than wildtype Rad51 when both proteins are expressed at near physiologic levels. We have recently purified Rad51 and caspase-3 proteins to allow in vitro mechanistic studies. We present new data showing Rad51 is mostly cytoplasmic in brca2--, and that wildtype BRCA2 expression relocates Rad51 to the nucleus whereas mutant BRCA2 expression does not effect Rad51 localization. These fundings lead to the following hypotheses: 1. BRCA2 normally functions in double strand DNA break repair; 2. BRCA2 and Rda51 function in the same biochemical pathway mediating DNA repair; 3. BRCA2 stabilizes Rad51 by inhabiting degradation by caspase-3 and other proteases; 4. BRCA2 influences nuclear localization of Rad51. To test hypothesis we propose these aims. Aim 1: Determine the functional domains of BRCA2 protein which mediate double strand break repair and tumorigenesis. Aim 2: See if known additional mutations in BRCA2 defective cancer cells contribute to radiation sensitivity & DNA repair defects in brca2-- cells. Aim 3: Determine the mechanism and in vivo significance off BRCA2- Rad51 interactions by in vitro assays. Aim 4: Analyze mechanism of BRCA2- Rad51 localization. Aim 5: Develop and use in Vivo imaging methods to study Rad51 localization and DNA repair in living cells, in real time.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IHC Test for BRCA1 Hereditary Ovarian Cancer
  • 批准号:
    8239640
  • 项目类别:
  • 资助金额:
    $39.92万
  • 财政年份:
    2010
  • 负责人:
    Jeffrey T Holt
  • 依托单位:
IHC Test for BRCA1 Hereditary Ovarian Cancer
  • 批准号:
    8259213
  • 项目类别:
  • 资助金额:
    $39.92万
  • 财政年份:
    2010
  • 负责人:
    Jeffrey T Holt
  • 依托单位:
IHC Test for BRCA1 Hereditary Ovarian Cancer
  • 批准号:
    7804771
  • 项目类别:
  • 资助金额:
    $16.36万
  • 财政年份:
    2010
  • 负责人:
    Jeffrey T Holt
  • 依托单位:
PARP Inhibitor Targeted Therapy for Breast Cancer
  • 批准号:
    7481522
  • 项目类别:
  • 资助金额:
    $14.9万
  • 财政年份:
    2008
  • 负责人:
    Jeffrey T Holt
  • 依托单位:
海外基金